Meeting of the Clinical Laboratory Improvement Advisory Committee

March 5, 2024
Notice of meeting.

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announced the following meeting for the Clinical Laboratory Improvement Advisory Committee (CLIAC).

This is a virtual meeting. It is open to the public, limited only by the number of webcast lines available. Time will be available for public comment, and the public is also welcome to submit written comments in advance of the meeting.

The meeting will be held on April 10, 2024, from 10 a.m. to 6 p.m., virtually. Meeting times are tentative and subject to change. The confirmed meeting times, agenda items, and meeting materials, including instructions for accessing the live meeting broadcast, will be available on the CLIAC website at Check the website on the day of the meeting for the web conference link.

The advice and guidance pertain to general issues related to improvement in clinical laboratory quality and laboratory medicine and specific questions related to possible revision of the Clinical Laboratory Improvement Amendments of 1988 (CLIA) standards. Examples include providing guidance on studies designed to improve quality, safety, effectiveness, efficiency, timeliness, equity, and patient-centeredness of laboratory services; revisions to the standards under which clinical laboratories are regulated; the impact of proposed revisions to the standards on medical and laboratory practice; and the modification of the standards and provision of non-regulatory guidelines to accommodate technological advances, such as new test methods, the electronic transmission of laboratory information, and mechanisms to improve the integration of public health and clinical laboratory practices.

The agenda will include agency updates from CDC, CMS, and FDA. Presentations and CLIAC discussions will focus on the applicability of CLIA personnel requirements to preanalytic testing, the role of artificial intelligence and machine learning in the clinical laboratory, and the use of clinical standards to improve laboratory quality. Agenda items are subject to change as priorities dictate.

Public comment periods for each agenda item are scheduled immediately prior to the Committee discussion period for that item. In general, each individual or group requesting to present an oral comment will be limited to a total time of five minutes (unless otherwise indicated). Speakers should email [email protected] at least five business days prior to the meeting date.

Visit the Federal Register for more information

Photo 111134338 © Kwanchaidt |
Photo 81363766 © Andrii Kucher |
Photo 125378010 © Komgrit Pradissagul |
Photo 36810879 © Tyler Olson |